Skeletal Myoblasts as a Therapeutic Agent

Progress in Cardiovascular Diseases

Volumn 50, Issue 1, 2007, Pages 7-17

  Menasché, Philippe ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOTRANSPLANTATION; CELL DIFFERENTIATION; CELL TYPE; CLINICAL TRIAL; EMBRYONIC STEM CELL; FEASIBILITY STUDY; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MYOBLAST; MYOTUBE; SAFETY; STEM CELL TRANSPLANTATION; TREATMENT INDICATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSPLANTATION; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEART DISEASES; HUMANS; MUSCLE FIBERS; MYOBLASTS, SKELETAL; MYOCARDIAL CONTRACTION; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 34447309600     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2007.02.002     Document Type: Article

References (61)

1. Murry C.E., Reinecke H., and Pabon L.M. Regeneration gaps: Observations on stem cells and cardiac repair. J Am Coll Cardiol 47 (2006) 1777-1778
2. Leor J., Patterson M., Quinones M.J., et al. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?. Circulation 94 9 Suppl (1996) II332-II336
3. Scorsin M., Hagege A.A., Marotte F., et al. Does transplantation of cardiomyocytes improve function of infracted myocardium?. Circulation 96 9 Suppl (1997) II-188-II-193
4. Dowell J.D., Rubart M., Pasumarthi K.B., et al. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58 (2003) 336-350
5. He K.L., Yi G.H., Sherman W., et al. Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J Heart Lung Transplant 24 (2005) 1940-1949
6. van den Bos E.J., Thompson R.B., Wagner A., et al. Functional assessment of myoblast transplantation for cardiac repair with magnetic resonance imaging. Eur J Heart Fail 7 (2005) 435-443
7. McConnell P.I., del Rio C.L., Jacoby D.B., et al. Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure. J Thorac Cardiovasc Surg 130 (2005) 1001-1009
8. Emani S.M., Ellis M.J., Dibernardo L.R., et al. Systolic contraction within aneurysmal rabbit myocardium following. Transplantation of autologous skeletal myoblasts. J Surg Res 135 (2006) 202-208
9. Leobon B., Garcin I., Menasche P., et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 100 (2003) 7808-7811
10. Rubart M., Soonpaa M.H., Nakajima H., et al. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 114 (2004) 775-783
11. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94 (2004) 678-685
12. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med (2005) 367-368
13. Chazaud B., Sonnet C., Lafuste P., et al. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol 163 (2003) 133-143
14. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
15. Siminiak T., Kalawski R., Fiszer D., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am Heart J 148 (2004) 531-537
16. Abraham M.R., Henrikson C.A., Tung L., et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 97 (2005) 159-167
17. Stagg M.A., Coppen S.R., Suzuki K., et al. Evaluation of frequency, type, and function of gap junctions between skeletal myoblasts overexpressing connexin43 and cardiomyocytes relevance to cell transplantation. FASEB J 20 (2006) 744-746
18. Itabashi Y., Miyoshi S., Yuasa S., et al. Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets. Cardiovasc Res 67 (2005) 561-570
19. Fernandes S., Amirault J.C., Lande G., et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc Res 69 (2006) 348-358
20. Fouts K., Fernandes B., Mal N., et al. Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium. Heart Rhythm 3 (2006) 452-461
21. Chen M., Fan Z.C., Liu X.J., et al. Effects of autologous stem cell transplantation on ventricular electrophysiology in doxorubicin-induced heart failure. Cell Biol Int 30 (2006) 576-582
22. Chang M.G., Tung L., Sekar R.B., et al. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation 113 (2006) 1832-1841
23. Soliman A.M., Krucoff M.W., Crater S., et al. Cell location may be a primary determinant of safety after myoblast transplantation into the infarcted heart. J Am Coll Cardiol 43 1 Suppl (2004) 15A
24. Bigger Jr. J.T. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337 (1997) 1569-1575
25. Menasche P., Hagege A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
26. Hagege A.A., Marolleau J.P., Vilquin J.T., et al. Skeletal myoblast transplantation in ischemic heart failure: Long-term follow-up of the first phase I cohort of patients. Circulation 114 1 Suppl (2006) I108-I113
27. Hagege A.A., Carrion C., Menasche P., et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361 (2003) 491-492
28. Gavira J.J., Herreros J., Perez A., et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 131 (2006) 799-804
29. Dib N., Michler R.E., Pagani F.D., et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Four-year follow-up. Circulation 112 (2005) 1748-1755
30. Brasselet C., Morichetti M.C., Messas E., et al. Skeletal myoblast transplantation through a catheter-based coronary sinus approach: An effective means of improving function of infarcted myocardium. Eur Heart J 26 (2005) 1551-1556
31. Siminiak T., Fiszer D., Jerzykowska O., et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: The POZNAN trial. Eur Heart J 26 (2005) 1188-1195
32. Biagini E., Valgimigli M., Smits P.C., et al. Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure. Eur J Heart Fail 8 (2006) 641-648
33. Dib N., Diethrich E.B., Campbell A., et al. A percutaneous swine model of myocardial infarction. J Pharmacol Toxicol Methods 53 (2006) 256-263
34. Hardiman O., Faustman D., Li X., et al. Expression of major histocompatibility complex antigens in cultures of clonally derived human myoblasts. Neurology 43 3 Pt 1 (1993) 604-608
35. Lee W.C., Chavez Y.E., Baker T., et al. Economic burden of heart failure: A summary of recent literature. Heart Lung 33 (2004) 362-371
36. Murry C.E., Field L.J., and Menasche P. Cell-based cardiac repair: Reflections at the 10-year point. Circulation 112 (2005) 3174-3183
37. Ott H.C., Brechtken J., Swingen C., et al. Robotic minimally invasive cell transplantation for heart failure. J Thorac Cardiovasc Surg 132 (2006) 170-173
38. Dow J., Simkhovich B.Z., Kedes L., et al. Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapy. Cardiovasc Res 67 (2005) 301-307
39. Memon I.A., Sawa Y., Fukushima N., et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 130 (2005) 1333-1341
40. Kondoh H., Sawa Y., Miyagawa S., et al. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters. Cardiovasc Res 69 (2006) 466-475
41. Maurel A., Azarnoush K., Sabbah L., et al. Can cold or heat shock improve skeletal myoblast engraftment in infracted myocardium?. Transplantation 80 (2005) 660-665
42. Min J.J., Ahn Y., Moon S., et al. In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium. Ann Nucl Med 20 (2006) 165-170
43. Kutschka I., Kofidis T., Chen I.Y., et al. Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation 114 1 Suppl (2006) I174-I180
44. Gheysens O., Lin S., Cao F., et al. Noninvasive evaluation of immunosuppressive drug efficacy on acute donor cell survival. Mol Imaging Biol 8 (2006) 163-170
45. Tambara K., Sakakibara Y., Sakaguchi G., et al. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108 Suppl 1 (2003) II259-II263
46. Kofidis T., Lebl D.R., Swijnenburg R.J., et al. Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur J Cardiothorac Surg 29 (2006) 50-55
47. Zhang M., Methot D., Poppa V., et al. Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J Mol Cell Cardiol 33 (2001) 907-921
48. Lim S.Y., Kim Y.S., Ahn Y., et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 70 (2006) 530-542
49. Yau T.M., Kim C., Ng D., et al. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann Thorac Surg 80 (2005) 1779-1786
50. Azarnoush K., Maurel A., Sebbah L., et al. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1-alpha. J Thorac Cardiovasc Surg 130 (2005) 173-179
51. Ott H.C., Bonaros N., Marksteiner R., et al. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Eur J Cardiothorac Surg (2004) 627-634
52. Memon I.A., Sawa Y., Miyagawa S., et al. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 130 (2005) 646-653
53. Christman K.L., Vardanian A.J., Fang Q., et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44 (2004) 654-660
54. Kutschka I., Chen I.Y., Kofidis T., et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 114 1 Suppl (2006) I167-I173
55. Davis M.E., Hsieh P.C., Takahashi T., et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 103 (2006) 8155-8160
56. Reinecke H., Poppa V., and Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34 (2002) 241-249
57. Winitsky S.O., Gopal T.V., Hassanzadeh S., et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol 3 (2005) e87
58. Oshima H., Payne T.R., Urish K.L., et al. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12 (2005) 1130-1141
59. Hodgson D.M., Behfar A., Zingman L.V., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287 (2004) H471-H479
60. Menard C., Hagege A.A., Agbulut O., et al. Transplantation of cardiac-committed mouse embryonic stem cells to infracted sheep myocardium: A preclinical study. Lancet 366 (2005) 1005-1112
61. Strasser H., Berjukow S., Marksteiner R., et al. Stem cell therapy for urinary stress incontinence. Exp Gerontol 39 (2004) 1259-1265